B
Bing Xu
Researcher at Brandeis University
Publications - 373
Citations - 29970
Bing Xu is an academic researcher from Brandeis University. The author has contributed to research in topics: Self-healing hydrogels & Cancer cell. The author has an hindex of 83, co-authored 357 publications receiving 26713 citations. Previous affiliations of Bing Xu include University of Pennsylvania & University of Hong Kong.
Papers
More filters
Journal ArticleDOI
Hyper‐Crosslinkers Lead to Temperature‐ and pH‐Responsive Polymeric Nanogels with Unusual Volume Change
Ning Zhou,Xiaoyan Cao,Xuewen Du,Huaimin Wang,Ming Wang,Shuang Liu,Khang Nguyen,Klaus Schmidt-Rohr,Qiaobing Xu,Gaolin Liang,Bing Xu +10 more
TL;DR: As the first example of the use of functional hyper-crosslinkers to control the pH and thermal responses of nanogels, this work illustrates a new way to design soft materials with unusual behaviors.
Journal ArticleDOI
Chirality Controls Reaction-Diffusion of Nanoparticles for Inhibiting Cancer Cells.
TL;DR: As the first example of chirality controlling RD process of NPs for inhibiting cancer cells, this work illustrates a fundamentally new way for developing nanomedicine based on RD processes and nanoparticles.
Journal ArticleDOI
Synthesis of novel conjugates of a saccharide, amino acids, nucleobase and the evaluation of their cell compatibility.
TL;DR: This article reports the synthesis of a novel type of conjugate of three fundamental biological build blocks (i.e., saccharide, amino acids, and nucleobase) and their cell compatibility and their conjugates are mammalian cell compatible.
Journal ArticleDOI
Supramolecular hydrogel of kanamycin selectively sequesters 16S rRNA
TL;DR: The hydrogel of kanamycin indicates that the hydrogels of aminoglycosides preserve the specific interaction with their macromolecular targets (e.g., 16S rRNA), thus illustrating a simple approach to explore and identify possible biological targets of supramolecular nanofibers/hydrogels.
Journal ArticleDOI
Ectoenzyme switches the surface of magnetic nanoparticles for selective binding of cancer cells.
Xuewen Du,Jie Zhou,Bing Xu +2 more
TL;DR: This work illustrates a fundamentally new concept to allow cells to actively engineer the surface of colloids materials, such as magnetic nanoparticles, for various applications as well as a general method to broadly target cancer cells without relying on specific ligand-receptor interactions.